Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women.
about
Interventions for preventing osteoporosis in women on heparin therapy during pregnancyInterventions for preventing osteoporosis in women on heparin therapy during pregnancyFrequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels.Differentiation of Caucasians and Chinese at bone mass candidate genes: implication for ethnic difference of bone mass.Pharmacogenetics of osteoporosis.A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy.Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus.Pharmacogenomic approaches to osteoporosis.How frequent is altered gene expression among susceptibility genes to human complex disorders?Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.Association between the vitamin D receptor gene polymorphism and osteoporosis.Pharmacogenetics of bone treatments: the VDR and ERalpha gene story.Genetics of the bone response to bisphosphonate treatmentsThe genetics of response to estrogen treatment.Bone mass pharmacogenetics and ethnic health implications.Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review.Pharmacogenetics of osteoporosis: what is the evidence?The future of pharmacogenetics for osteoporosis.The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes.Oestrogen receptor-alpha polymorphism and risk of fracture: a meta-analysis of 13 studies including 1279 cases and 6069 controls.Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.Long-term 1,25(OH)2 vitamin D therapy increases bone mineral density in osteopenic women. Comparison with the effect of plain vitamin D.Vitamin D receptor (VDR) gene polymorphism influences the risk of osteoporosis in postmenopausal women of Northwest India.Associations between ERα/β gene polymorphisms and osteoporosis susceptibility and bone mineral density in postmenopausal women: a systematic review and meta-analysis.Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open-label, long-term safety and efficacy study.Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata.Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis
P2860
Q24187670-91640185-4F31-4BA9-8338-62FFC568CE1DQ24235131-D6EB7889-B4DC-44C9-8C44-39EBB22040A9Q34069915-C5B4330F-3678-4308-ADE3-EB72981788FAQ34221701-85BBE4DC-B31B-40EE-9161-77D64B068ED1Q34343493-4D0418CF-3ACA-4B4F-B8D3-D3793ED6DE34Q35381094-34189CD7-F9D7-415E-BC34-FD51C073ECE2Q35553302-A7D961B3-F87E-41A9-BD92-C035B868838AQ35570345-35BF30E4-4E7F-4191-A710-8B024378D812Q36043405-594F4A25-77C1-4BA7-BF8A-1D0936BF46A8Q36765764-91E0EDBC-70C2-4D2F-B037-489F9D57D883Q37107934-66A56562-122D-4B6F-9361-BA4B2634C07EQ37179537-FC33D587-DE34-4071-9F43-86FB66AF5B74Q37430395-C447237B-410E-48AE-91ED-34C117A1D809Q37430419-532FEC51-CFE5-4C4A-B795-72274580B7D9Q37430515-3E538BE5-B65E-4172-9241-BE47A73FE8EDQ37637677-F8ACAEBB-9D74-43DD-A866-DF608814F4E1Q37682805-B13561A5-5D95-4F51-9FEC-0A0A272D9D13Q38023738-41F6DC8A-197E-4F24-A486-8B809B2EB859Q38097533-07B9A966-2AC2-4C4B-BCB6-9DDA74670347Q43244965-39AE691A-2905-45A1-823B-706ADAB68840Q43422421-781B53ED-7FDE-489A-A781-F48D321DBB65Q44276623-4C4EB248-253B-47A7-9807-2E794BF34B70Q46418934-CC115756-B149-4256-9F80-5D05E3250885Q46825407-0B326CBC-73D5-49C0-AB3D-D00AFEB30AB3Q47705456-9AF032EE-1670-4ECE-9453-0DAABFB332B0Q49843874-472EB088-845D-4C27-BDD5-DEA100DED949Q50113877-E854031D-CC38-4D15-9F08-3FBE9B7F1844Q50669216-D1FF48D9-8D14-4B10-A5E7-C95EDFFCA83AQ57487017-7E4C7AAC-C98E-4DC9-B859-63D5EED56B63
P2860
Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Association of vitamin D and e ...... ral density in Japanese women.
@en
Association of vitamin D and e ...... ral density in Japanese women.
@nl
type
label
Association of vitamin D and e ...... ral density in Japanese women.
@en
Association of vitamin D and e ...... ral density in Japanese women.
@nl
prefLabel
Association of vitamin D and e ...... ral density in Japanese women.
@en
Association of vitamin D and e ...... ral density in Japanese women.
@nl
P2093
P1476
Association of vitamin D and e ...... ral density in Japanese women.
@en
P2093
Kurabayashi T
Matsushita H
Takakuwa K
P304
P356
10.1016/S0002-9378(99)70603-4
P407
P577
1999-05-01T00:00:00Z